Tag : DEPRESSION

Depression during pregnancy affects both maternal and fetal health, but many women stop taking antidepressants due to safety concerns. A recent study shows nearly 49% discontinue use without increasing psychotherapy, emphasizing the need for better clinician-patient discussions.

This study provided evidence of the possible existence of a dose-response relationship with venlafaxine. Depression is a major contributor to disability, affecting 322 million people or 4.4% of the world’s population.1 Its prevalence has been increasing over the years by an estimated 18% between 2005 and 2015. The management of depression includes non-pharmacological options such as psychotherapy or pharmacological options, mainly the second-generation antidepressants such as first-line serotonin reuptake inhibitors (SSRIs).